NIFTY 50
26,027.30 (-0.08%)
NIFTY IT
38,386.25 (0.29%)
NIFTY AUTO
27,568.10 (-0.91%)
NIFTY FINANCIAL SERVICES
27,603.15 (-0.25%)
NIFTY BANK
59,461.80 (0.12%)
NIFTY REALTY
886.15 (-0.05%)
NIFTY ENERGY
35,028.15 (-0.03%)
NIFTY METAL
10,553.15 (0.16%)
NIFTY FMCG
54,868.40 (0.69%)
NIFTY HEALTH CARE
14,711.20 (-0.29%)
NIFTY PHARMA
22,719.40 (-0.39%)
NIFTY MEDIA
22,719.40 (-0.39%)
Platforms
Webinars
Insights
Research
Videos
Markets
Equity
Derivatives
IPO
Other Markets
Corporate Information
Pricing
Support
Login
Login to Trade
Login to Reports
Open an Account
Home
Platform
Insights
Research
Markets
Pricing
Support
Login
Open an Account
Trend of Stock Market
A trend is the broad upward or downward movement of a stock's price over time
Forthcoming IPO
Open Issues
Closed Issue
Top Gainers / Losers
52 Weeks High/ Low
Value / Volume Toppers
Get Quotes
Nifty Futures
Top Traded Quantity
Top Traded Value
Derivative Summary
Daily Settlement Price
List Of Underlying
Put Call Ratio
FII Statistics
Most Active Contract
All Index Futures
Top Gainers
Top Losers
Highest In OI
Lowest In OI
Increase In OI
Decrease In OI
Most Active Calls
Most Active Put
Top Gainers
Top Losers
Highest In OI
Lowest In OI
Increase In OI
Decrease In OI
Forthcoming Issues
Open Issues
Closed Issue
World Indices
ADR Prices
MF Investment
FII Investment
Get Quotes
Company Snapshot
Company Background
Board of Directors
Directors Reports
Profit & Loss
Balance Sheet
Quarterly Results
Shareholding Pattern
Key Financial Ratios
Mutual Fund Holdings
Peer Comparison
Technical Chart
Company News
Change Company Name
Dr Reddys Laboratories Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
500124
ISIN Demat
INE089A01031
Book Value
377.56
NSE Symbol
DRREDDY
Dividend Yield (%)
0.62
Market Cap (
₹
Cr.)
106,803.47
P/E
19.78
EPS
64.68
Face Value
1
Date
Headline
09-Dec-25
Dr Reddys Laboratories allots 9,165 equity shares under ESOS
24-Nov-25
Dr. Reddy's receives EC marketing authorization for AVT03 (denosumab)
13-Nov-25
Dr Reddys Laboratories allots 7,430 equity shares under ESOS
10-Nov-25
Dr Reddys announces change in senior management
23-Sep-25
Dr Reddys Laboratories schedules board meeting
15-Sep-25
Dr. Reddy's allots 6,475 equity shares under ESOP
01-Sep-25
Dr Reddys Laboratories announces resignation of Chief Human Resources Officer
29-Aug-25
Dr Reddys Laboratories allots 21,350 equity shares under ESOP
20-Aug-25
Dr Reddys Laboratories allots 4,160 equity shares under ESOS
24-Jun-25
Dr Reddys Laboratories to hold board meeting
Prev
1
2
3
Next